Skip to main content
Premium Trial:

Request an Annual Quote

Finnish Red Cross to Use GeneGo's Software for Blood, Transplant Studies

NEW YORK (GenomeWeb News) —The Finnish Red Cross has licensed GeneGo’s bioinformatics software for use in clinical and research projects it plans to conduct on blood taken from transfusion patients, GeneGo said today.
 
The FRC Blood Service will use the MetaCore and MetaDrug bioinformatics and chemoinformatics suites for blood group and cell type analysis from blood transfusions as well as for tissue typing of donors involved in organ, bone marrow, cord blood, and bone marrow stem cell replacement transplants.
 
The MetaCore 5.0 is used to help target, validate, and identify biomarkers for disease states and toxicology, and the MetaDrug 5.0 is used to predict toxicity, metabolism, and the effects of novel small molecules.
 
Financial terms of the agreement were not released.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.